{"id":"W2154738014","doi":"10.1111/jth.13153","title":"Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial","year":2015,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Apixaban; Venous thromboembolism; Medicine; Cancer; Internal medicine; Intensive care medicine; Rivaroxaban; Atrial fibrillation; Thrombosis; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001149099,0.001029938,0.002270323,0.0001978602,0.0002079136,0.001279343,0.0004586053,0.0008573536,0.002432866],"category_scores_gemma":[0.002566211,0.000302115,0.002043073,0.0003249528,0.0004974842,0.0007734033,0.0003628311,0.002404051,0.0004298843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004119139,"about_ca_system_score_gemma":0.000503061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004526283,"about_ca_topic_score_gemma":0.0009108971,"domain_scores_codex":[0.9994594,0.0002942565,0.00004034373,0.00007422245,0.00006403876,0.00006774654],"domain_scores_gemma":[0.9990591,0.0003751813,0.0002586952,0.00008981893,0.00005068994,0.0001664896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8994598,0.001835543,0.008330864,0.002530125,0.008447064,0.000247174,0.0001266115,0.001308573,0.004358904,0.0006593173,0.00453987,0.06815614],"study_design_scores_gemma":[0.8722267,0.05422414,0.04443722,0.000353012,0.01573029,0.0006487858,0.0001778087,0.001716774,0.001539836,0.001185648,0.007669732,0.00009011533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691133,0.02397506,0.0003503389,0.001440944,0.0002967913,0.000285829,0.001418772,0.00006984362,0.003049136],"genre_scores_gemma":[0.9821427,0.01157469,0.0006440563,0.001007841,0.0005695763,0.0003727131,0.002111058,0.00002295043,0.001554335],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002432866,"threshold_uncertainty_score":0.008138716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1618100712664076,"score_gpt":0.3822552678402218,"score_spread":0.2204451965738141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}